<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0070">
 <label>14</label>
 <element-citation publication-type="journal" id="sbref0070">
  <person-group person-group-type="author">
   <name>
    <surname>Alig</surname>
    <given-names>S.K.</given-names>
   </name>
   <name>
    <surname>Dreyling</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Seppi</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Aulinger</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Witkowski</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature</article-title>
  <source>Eur J Haematol.</source>
  <volume>94</volume>
  <issue>6</issue>
  <year>2015</year>
  <fpage>554</fpage>
  <lpage>557</lpage>
  <pub-id pub-id-type="doi">10.1111/ejh.12396</pub-id>
  <pub-id pub-id-type="pmid">24913471</pub-id>
 </element-citation>
</ref>
